原发性闭角型青光眼:已知与未知
本文综述原发性闭角型青光眼(PACG)的病理机制、遗传学进展、分类争议及治疗策略,指出除瞳孔阻滞和虹膜高褶外,脉络膜厚度和葡萄膜扩张等多机制更常见,激光周边虹膜切开术/成形术及白内障摘除术被证明有效,未来需探索预防性治疗及新治疗策略。
要点
- 除瞳孔阻滞和虹膜高褶外,脉络膜厚度和葡萄膜扩张等多机制更常见于房角关闭。
- 全基因组关联研究已发现多个新的PACG位点和基因,可能揭示其分子机制。
- 激光周边虹膜切开术和/或虹膜成形术及白内障摘除术被证明可开放房角或阻止关闭。
核心结论
- PACG的当前分类系统仍存在争议,聚焦前房角是主要管理策略。
- 若未来研究能识别哪些房角和/或个体更可能从预防性治疗中获益,PACG在早期可能可预防。
- 需要调整心理状态和平衡交感-副交感神经活动的新治疗策略及创新药物来改善PACG预后。
研究设计与样本
- 本文为综述,旨在描述PACG的当前认识和未知方面,并分享作者的临床经验和观点。
主要发现
- 除瞳孔阻滞和虹膜高褶外,脉络膜厚度和葡萄膜扩张等多机制更常见于房角关闭,可能是PACG表现特征的原因。
- 近期全基因组关联研究识别了多个新的PACG位点和基因。
- 激光周边虹膜切开术和/或虹膜成形术以及白内障摘除术被证明可有效开放房角或阻止房角关闭过程。
关键数值与推荐
- 原文未报告具体推荐条款或数值标准。
临床怎么用
- 聚焦前房角是PACG的主要管理策略。
- 激光周边虹膜切开术和/或虹膜成形术以及白内障摘除术被证明可有效开放房角或阻止房角关闭。
局限性
- PACG的当前分类系统仍存在争议。
- 需要未来研究识别哪些房角和/或个体更可能从预防性治疗中获益。
- 需要新治疗策略和创新药物来改善PACG预后。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Primary angle-closure glaucoma (PACG) is a common cause of blindness. Angle closure is a fundamental pathologic process in PAGC. With the development of imaging devices for the anterior segment of the eye, a better understanding of the pathogenesis of angle closure has been reached. Aside from pupillary block and plateau iris, multiple-mechanisms are more common contributors for closure of the angle such as choroidal thickness and uveal expansion, which may be responsible for the presenting features of PACG. Recent Genome Wide Association Studies identified several new PACG loci and genes, which may shed light on the molecular mechanisms of PACG. The current classification systems of PACG remain controversial. Focusing the anterior chamber angle is a principal management strategy for PACG. Treatments to open the angle or halt the angle closure process such as laser peripheral iridotomy and/or iridoplasty, as well as cataract extraction, are proving their effectiveness. PACG may be preventable in the early stages if future research can identify which kind of angles and/or persons are more likely to benefit from prophylactic treatment. New treatment strategies like adjusting the psychological status and balancing the sympathetic-parasympathetic nerve activity, and innovative medicines are needed to improve the prognosis of PACG. In this review, we intend to describe current understanding and unknown aspects of PACG, and to share the clinical experience and viewpoints of the authors.
引用
- Sun X, Dai Y, Chen Y, et al. Primary angle closure glaucoma: What we know and what we don't know. Prog Retin Eye Res. 2016. PMID: 28039061. doi:10.1016/j.preteyeres.2016.12.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。